Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reported that micro-needling with Low-Level LED Therapy and Growth Factors may improve hair density in mild-to-moderate hair loss and telogen effluvium related to COVID-19, based on preliminary observations.

This study found that androgenetic alopecia can affect the occipital region in men with advanced stages of the condition.

This study found that certain VDR gene polymorphisms are more prevalent in female pattern hair loss patients than in healthy controls, suggesting these polymorphisms may increase disease risk.

In this study, a significant positive correlation between clinical hyperandrogenism and free androgen index was found in younger women with PCOS, but not in older women.

In this study, it was found that 39.6% of the women in Isfahan aged 20 to 70 had androgenetic alopecia, and lower ferritin levels were linked to more severe cases.

This pilot study found that intradermal 10% glucose combined with non-cross-linked hyaluronic acid improved hair density and diameter more than hyaluronic acid alone in adults with androgenetic alopecia, with no serious adverse events.

This exploratory pilot study reported that using a 2% Oleosome-FGF-2 fusion extract scalp serum twice daily for 84 days in women with telogen effluvium and brittle hair improved hair density, anagen/telogen ratio, hair shaft thickness, and scalp hydration compared to a placebo.

This review discusses the pathophysiology, molecular events, and therapeutic options for androgenetic alopecia, but reports no new clinical findings.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

This review explores the complex pathophysiology of androgenetic alopecia, highlighting genetic factors, androgen metabolism, and emerging therapies such as platelet-rich plasma and low-level laser therapy, but notes that no ultimate cure exists and treatments focus on slowing progression and promoting hair growth.

The device improved hair growth and thickness in men without side effects.

In this study, the authors highlighted treatments for androgenetic alopecia, noting that combination therapies with drugs like minoxidil and antiandrogens often require at least 6 months for clinical improvement, while also emphasizing the value of patient counseling for informed treatment choices.

This case report describes the first observed instance of fibrosing alopecia in a pattern distribution in a child, suggesting the condition is not solely androgen dependent.

This study proposes a new treatment protocol combining autologous regenerative therapy with mesotherapy and photobiostimulation for androgenetic alopecia, leveraging adipose-derived stem cells to stimulate hair follicle regeneration.

This study found that frequent consumption of sweetened tea drinks is linked to an increased risk of female androgenetic alopecia, with the risk further heightened by late bedtimes, but sleep behavior rather than sugar intake mediates the association.

This paper reviews the autoimmune disorder alopecia areata, its progression, and its significant emotional and psychological impact, but reports no new clinical findings.

This study developed and validated the Hair-Shedding Visual Scale for Asian Women, finding it to be an effective tool for identifying FPHL and TE.

This study found that males with a maternal history of androgenetic alopecia were significantly more likely to have female pattern hair loss, suggesting early screening might be beneficial.

This case report and literature review concluded that using the follicular unit extraction technique for hair transplants in androgenetic alopecia patients yields satisfactory aesthetic results and high patient satisfaction over 12 months.

The document reviews the latest and most effective hair restoration techniques for male and female hair loss.

This article discusses disruptions in hair cycle dynamics and follicular miniaturization associated with patterned hair loss, emphasizing androgen-related changes, and reports no clinical findings.

This study observed a decrease in hair density and average hair diameter, along with an increase in hair loss, among females with androgenic alopecia compared to healthy controls.

This abstract discusses the effects of androgenetic alopecia on men's and women's quality of life but reports no new research findings.

This study found that platelet-rich plasma therapy significantly improved hair density, diameter, and reduced inflammation in androgenetic alopecia patients compared to placebo, though individual responses varied.

This case study discussed a postmenopausal female with androgenic alopecia and hirsutism due to a Leydig cell tumor, suggesting the importance of further workup in women with severe hirsutism or androgenic alopecia.